• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

替考拉宁、万古霉素、A16686、克林霉素、红霉素和夫西地酸对厌氧菌的体外活性。

In vitro activity of teicoplanin, vancomycin, A16686, clindamycin, erythromycin and fusidic acid against anaerobic bacteria.

作者信息

Hassan H, O'Hare M D, Felmingham D

机构信息

Department of Medical Microbiology, Faculty of Medicine, University of Malaya, Kuala Lumpur.

出版信息

Singapore Med J. 1990 Feb;31(1):56-8.

PMID:2139737
Abstract

The in vitro activity of teicoplanin and A16686, two new glycopeptide antibiotics was determined against 196 isolates of anaerobic bacteria. The activity of teicoplanin and A16686, in comparison with that of vancomycin, clindamycin, erythromycin and fusidic acid was 2 to 16 times higher against the gram positive anaerobes, namely, Propionibacterium acnes, Clostridium perfringens, Clostridium difficile, Clostridium species, Peptococcus species and Peptostreptococcus species. However, Bacteroides fragilis was resistant to teicoplanin and A16686 while Bacteroides melaninogenicus and Bacteroides bivius were found to be sensitive.

摘要

测定了两种新型糖肽类抗生素替考拉宁和A16686对196株厌氧菌的体外活性。与万古霉素、克林霉素、红霉素和夫西地酸相比,替考拉宁和A16686对革兰氏阳性厌氧菌,即痤疮丙酸杆菌、产气荚膜梭菌、艰难梭菌、梭菌属、消化球菌属和消化链球菌属的活性高2至16倍。然而,脆弱拟杆菌对替考拉宁和A16686耐药,而产黑素拟杆菌和二路拟杆菌敏感。

相似文献

1
In vitro activity of teicoplanin, vancomycin, A16686, clindamycin, erythromycin and fusidic acid against anaerobic bacteria.替考拉宁、万古霉素、A16686、克林霉素、红霉素和夫西地酸对厌氧菌的体外活性。
Singapore Med J. 1990 Feb;31(1):56-8.
2
In vitro activity of vancomycin and teicoplanin against anaerobic bacteria.万古霉素和替考拉宁对厌氧菌的体外活性。
Drugs Exp Clin Res. 1987;13(9):551-4.
3
Antimicrobial susceptibility of anaerobic bacteria in Sweden in 1983.1983年瑞典厌氧菌的抗菌药敏情况。
Scand J Infect Dis Suppl. 1984;43:44-9.
4
In vitro activities of ramoplanin, teicoplanin, vancomycin, linezolid, bacitracin, and four other antimicrobials against intestinal anaerobic bacteria.雷莫拉宁、替考拉宁、万古霉素、利奈唑胺、杆菌肽及其他四种抗菌药物对肠道厌氧菌的体外活性
Antimicrob Agents Chemother. 2003 Jul;47(7):2334-8. doi: 10.1128/AAC.47.7.2334-2338.2003.
5
In vitro activity of LY 333328 against anaerobic gram-positive bacteria.
J Chemother. 1999 Apr;11(2):90-2. doi: 10.1179/joc.1999.11.2.90.
6
In-vitro studies with ramoplanin (MDL 62,198): a novel lipoglycopeptide antimicrobial.雷莫拉宁(MDL 62,198)的体外研究:一种新型脂糖肽类抗菌药物。
J Antimicrob Chemother. 1990 Feb;25(2):217-20. doi: 10.1093/jac/25.2.217.
7
Comparative in-vitro activity of Sch 34343 and other antimicrobial agents against anaerobic bacteria.Sch 34343与其他抗菌剂对厌氧菌的体外活性比较
J Antimicrob Chemother. 1985 Jun;15 Suppl C:183-8. doi: 10.1093/jac/15.suppl_c.183.
8
[Activity of fusidic acid on strictly anaerobic bacteria].
Pathol Biol (Paris). 1987 May;35(5):577-80.
9
In vitro bactericidal activity of the glycopeptide compounds vancomycin, teicoplanin and ramoplanin (A-16686/MDL 62,198).
J Chemother. 1989 Jul;1(4 Suppl):210-1.
10
In vitro activities of ramoplanin and four glycopeptide antibiotics against clinical isolates of Clostridium difficile.雷莫拉宁和四种糖肽类抗生素对艰难梭菌临床分离株的体外活性
Antimicrob Agents Chemother. 1991 Jan;35(1):195-7. doi: 10.1128/AAC.35.1.195.

引用本文的文献

1
Teicoplanin. A reappraisal of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy.替考拉宁:对其抗菌活性、药代动力学特性及治疗效果的重新评估
Drugs. 1994 May;47(5):823-54. doi: 10.2165/00003495-199447050-00008.